| Professional Services Industry | Industrials Sector | Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D. CEO | XMUN Exchange | JP3379950003 ISIN |
| Japan Country | 1,531 Employees | 29 Sep 2026 Last Dividend | 27 Sep 2005 Last Split | - IPO Date |
Shin Nippon Biomedical Laboratories, Ltd., established in 1957 and based in Kagoshima, Japan, operates as a comprehensive contract research organization (CRO) with a global footprint. The company specializes in a myriad of services ranging from non-clinical to clinical research stages, contributing significantly to the pharmaceutical and biotech sectors. Its operations are diverse, offering in-depth studies and support services in the development of pharmaceuticals and therapeutics, alongside engaging in renewable energy generation, hospitality, and wellbeing sectors — illustrating a versatile business model that extends beyond biomedical research.